| Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates YF Kang, C Sun, Z Zhuang, RY Yuan, Q Zheng, JP Li, PP Zhou, XC Chen, ... ACS nano 15 (2), 2738-2752, 2021 | 171 | 2021 |
| The effect of exercise during pregnancy on gestational diabetes mellitus in normal-weight women: a systematic review and meta-analysis WK Ming, W Ding, CJP Zhang, L Zhong, Y Long, Z Li, C Sun, Y Wu, ... BMC pregnancy and childbirth 18, 1-9, 2018 | 123 | 2018 |
| Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants C Sun, C Xie, GL Bu, LY Zhong, MS Zeng Signal Transduction and Targeted Therapy 7 (1), 202, 2022 | 85 | 2022 |
| PD-1+ CXCR5− CD4+ Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma JP Li, CY Wu, MY Chen, SX Liu, SM Yan, YF Kang, C Sun, JR Grandis, ... Journal for immunotherapy of cancer 9 (7), 2021 | 48 | 2021 |
| Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants YF Kang, C Sun, J Sun, C Xie, Z Zhuang, HQ Xu, Z Liu, YH Liu, S Peng, ... Nature communications 13 (1), 2674, 2022 | 36 | 2022 |
| Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants C Sun, YF Kang, YT Liu, XW Kong, HQ Xu, D Xiong, C Xie, YH Liu, ... Signal Transduction and Targeted Therapy 7 (1), 42, 2022 | 30 | 2022 |
| The status and prospects of Epstein–Barr virus prophylactic vaccine development C Sun, X Chen, Y Kang, M Zeng Frontiers in Immunology 12, 677027, 2021 | 30 | 2021 |
| A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus QY Zhu, S Shan, J Yu, SY Peng, C Sun, Y Zuo, LY Zhong, SM Yan, ... Nature Communications 12 (1), 6624, 2021 | 25 | 2021 |
| Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma W He, M Hou, H Zhang, C Zeng, S He, X Chen, M Xu, C Sun, W Jiang, ... International journal of cancer 144 (6), 1421-1431, 2019 | 20 | 2019 |
| Immunization with a self-assembled nanoparticle vaccine elicits potent neutralizing antibody responses against EBV infection YF Kang, X Zhang, XH Yu, Q Zheng, Z Liu, JP Li, C Sun, XW Kong, ... Nano Letters 21 (6), 2476-2486, 2021 | 19 | 2021 |
| How EBV infects: the tropism and underlying molecular mechanism for viral infection GL Bu, C Xie, YF Kang, MS Zeng, C Sun Viruses 14 (11), 2372, 2022 | 18 | 2022 |
| Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion X Zhang, J Hong, L Zhong, Q Wu, S Zhang, Q Zhu, H Chen, D Wei, R Li, ... Proceedings of the National Academy of Sciences 119 (32), e2202371119, 2022 | 16 | 2022 |
| Neuropilin 1 is an entry receptor for KSHV infection of mesenchymal stem cell through TGFBR1/2-mediated macropinocytosis ZZ Lu, C Sun, X Zhang, Y Peng, Y Wang, Y Zeng, N Zhu, Y Yuan, ... Science Advances 9 (21), eadg1778, 2023 | 10 | 2023 |
| Eliciting women’s preference for prenatal testing in China: a discrete choice experiment L Wu, Y Wu, S Zou, C Sun, J Chen, X Li, Z Lin, L Guan, Q Zeng, S Zhao, ... BMC Pregnancy and Childbirth 20, 1-8, 2020 | 9 | 2020 |
| Association between antibody responses to Epstein-Barr virus glycoproteins, neutralization of infectivity, and the risk of nasopharyngeal carcinoma QY Zhu, XW Kong, C Sun, SH Xie, A Hildesheim, SM Cao, MS Zeng Msphere 5 (6), 10.1128/msphere. 00901-20, 2020 | 8 | 2020 |
| A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV C Sun, YF Kang, XY Fang, YN Liu, GL Bu, AJ Wang, Y Li, QY Zhu, ... Cell Host & Microbe 31 (11), 1882-1897. e10, 2023 | 6 | 2023 |
| Anti‐EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy C Xie, LY Zhong, GL Bu, GX Zhao, BY Yuan, YT Liu, C Sun, MS Zeng Journal of Medical Virology 95 (5), e28793, 2023 | 6 | 2023 |
| EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells XD Dong, Y Li, Y Li, C Sun, SX Liu, H Duan, R Cui, Q Zhong, YG Mou, ... PLoS Pathogens 19 (5), e1011304, 2023 | 5 | 2023 |
| Vesicular Stomatitis Virus-Based Epstein-Barr Virus Vaccines Elicit Strong Protective Immune Responses XW Kong, X Zhang, GL Bu, HQ Xu, YF Kang, C Sun, QY Zhu, RB Ma, ... Journal of Virology 96 (9), e00336-22, 2022 | 4 | 2022 |
| Genomic Profiling of Radiation-Induced Sarcomas Reveals the Immunologic Characteristics and Its Response to Immune Checkpoint Blockade DC Hong, J Yang, C Sun, YT Liu, LJ Shen, BS Xu, Y Que, X Xia, X Zhang Clinical Cancer Research 29 (15), 2869-2884, 2023 | 3 | 2023 |
xiao zhangAssociate professor, Chongqing Medical University在 cqmu.edu.cn 的电子邮件经过验证
